NCT01891383

Brief Summary

The objective of this study is to measure the frequency and clinical types of mild cognitive impairment (MCI) or dementia that occur among up to 150 military retirees with and without a history of traumatic brain injury (TBI) among residents of the Armed Forces Retirement Home, Washington D.C. and the Veterans Home of California-Yountville. Investigators will compare the characteristics of dementia in those who have had a prior TBI to the characteristics in those without a history of TBI. It is our hypothesis that the dementia or MCI among those with prior TBI has distinct neuropsychological features that distinguishes it from those with dementia or MCI without a history of TBI.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2013

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 25, 2013

Completed
6 days until next milestone

Study Start

First participant enrolled

July 1, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 3, 2013

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

January 18, 2019

Status Verified

January 1, 2019

Enrollment Period

2.9 years

First QC Date

June 25, 2013

Last Update Submit

January 16, 2019

Conditions

Keywords

DementiaTraumatic brain injury (TBI)Mild cognitive impairment (MCI)Chronic traumatic encephalopathy (CTE)Remote effects of TBIPost-traumatic stress disorder (PTSD_

Outcome Measures

Primary Outcomes (1)

  • Prevalence of dementia or MCI in the two groups (TBI versus no TBI)

    The primary outcome will be the prevalence of dementia/MCI in the two groups (i.e. those with and without a TBI).

    Single visit, 4 hours.

Secondary Outcomes (1)

  • Characterization of the types of dementia or MCI that occur in the two groups (TBI or no TBI)

    Single visit, 4 hours.

Study Arms (2)

History of TBI

The history of TBI will be assessed by the subject's answers to the Ohio State University Traumatic Brain Injury Identification Method Short Form (OSU TBI-ID SF).

No history of TBI

The history of TBI will be assessed by the subject's answers to the Ohio State University Traumatic Brain Injury Identification Method Short Form (OSU TBI-ID SF).

Eligibility Criteria

Age50 Years - 95 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects for this study will be recruited from the Armed Forces Retirement Home (AFRH) in Washington, DC and the Veterans Home of California- Yountville. Up to 150 AFRH residents from both the independent living and the assisted living facilities will be invited to take the screening questionnaire and enroll in the study.

You may qualify if:

  • Cases (with a history of TBI):
  • Ages 50-95 years
  • History of traumatic brain injury of sufficient severity to have resulted in medical attention (ascertained via the Ohio State University TBI Identification Questionnaire-OSU TBI-ID, and based on DoD/VA criteria)
  • Residence in AFRH-Washington D.C. or the Veterans Home of California-Yountville
  • MMSE score ≥ 20
  • Capacity to provide consent to participate in research (assessment made by study physician)
  • Ability to read and write English
  • Controls (without a history of TBI):
  • Ages 50-95 years
  • No history of traumatic brain injury of sufficient severity to have resulted in medical attention (ascertained via the Ohio State University TBI Identification Questionnaire-OSU TBI-ID)
  • Residence in AFRH-Washington or the Veterans Home of California-Yountville
  • MMSE score ≥ 20
  • Capacity to provide consent or assent to participate in research
  • Ability to read and write English -

You may not qualify if:

  • Cases (with a history of TBI):
  • History of penetrating brain injury
  • History of disabling neurological or psychiatric condition such as epilepsy (besides posttraumatic epilepsy), multiple sclerosis, cortical stroke, hypoxic-ischemic encephalopathy, encephalitis, or schizophrenia
  • Controls (without a history of TBI):
  • History of disabling neurological or psychiatric condition such as epilepsy, multiple sclerosis, cortical stroke, hypoxic-ischemic encephalopathy, encephalitis, or schizophrenia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

California Veterans Home-Yountville

Yountville, California, 94599, United States

Location

Armed Forces Retirement Home

Washington D.C., District of Columbia, 20011-8400, United States

Location

MeSH Terms

Conditions

DementiaBrain Injuries, TraumaticCognitive DysfunctionChronic Traumatic EncephalopathyStress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersBrain InjuriesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesCognition DisordersBrain Injury, ChronicNeurodegenerative DiseasesBrain Damage, ChronicChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsStress Disorders, TraumaticTrauma and Stressor Related Disorders

Study Officials

  • Ramon Diaz-Arrastia, M.D., Ph.D.

    Uniformed Services University of the Health Sciences

    PRINCIPAL INVESTIGATOR
  • Kristine Yaffe, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Clinical Research, Center for Neuroscience and Regenerative Medicine; Professor of Neurology

Study Record Dates

First Submitted

June 25, 2013

First Posted

July 3, 2013

Study Start

July 1, 2013

Primary Completion

June 1, 2016

Study Completion

August 1, 2016

Last Updated

January 18, 2019

Record last verified: 2019-01

Locations